Literature DB >> 25910422

Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia.

Ivan Cordon1, María Jesús Nicolás1, Sandra Arrieta1, Eneko Lopetegui1, Jon López-Azcárate1, Manuel Alegre2, Julio Artieda3, Miguel Valencia4.   

Abstract

Recent studies have suggested the implication of the basal ganglia in the pathogenesis of schizophrenia. To investigate this hypothesis, here we have used the ketamine model of schizophrenia to determine the oscillatory abnormalities induced in the rat motor circuit of the basal ganglia. The activity of free moving rats was recorded in different structures of the cortico-basal ganglia circuit before and after an injection of a subanesthesic dose of ketamine (10mg/kg). Spectral estimates of the oscillatory activity, phase-amplitude cross-frequency coupling interactions (CFC) and imaginary event-related coherence together with animals׳ behavior were analyzed. Oscillatory patterns in the cortico-basal ganglia circuit were highly altered by the effect of ketamine. CFC between the phases of low-frequency activities (delta, 1-4; theta 4-8Hz) and the amplitude of high-gamma (~80Hz) and high-frequency oscillations (HFO) (~150Hz) increased dramatically and correlated with the movement increment shown by the animals. Between-structure analyses revealed that ketamine had also a massive effect in the low-frequency mediated synchronization of the HFO's across the whole circuit. Our findings suggest that ketamine administration results in an aberrant hypersynchronization of the whole cortico-basal circuit where the tandem theta/HFO seems to act as the main actor in the hyperlocomotion shown by the animals. Here we stress the importance of the basal ganglia circuitry in the ketamine model of schizophrenia and leave the door open to further investigations devoted to elucidate to what extent these abnormalities also reflect the prominent neurophysiological deficits observed in schizophrenic patients.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Animal models; Cortico-basal ganglia network; Cross-frequency coupling; Hyperlocomotion; Ketamine; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25910422     DOI: 10.1016/j.euroneuro.2015.04.004

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  16 in total

1.  Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states.

Authors:  Ingeborg H Hansen; Claus Agerskov; Lars Arvastson; Jesper F Bastlund; Helge B D Sørensen; Kjartan F Herrik
Journal:  Eur J Neurosci       Date:  2019-04-01       Impact factor: 3.386

2.  Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

3.  Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes.

Authors:  Eugenia Tomasella; Lucila Bechelli; Mora Belén Ogando; Camilo Mininni; Mariano N Di Guilmi; Fernanda De Fino; Silvano Zanutto; Ana Belén Elgoyhen; Antonia Marin-Burgin; Diego M Gelman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

4.  Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.

Authors:  Maya Slovik; Boris Rosin; Shay Moshel; Rea Mitelman; Eitan Schechtman; Renana Eitan; Aeyal Raz; Hagai Bergman
Journal:  J Neurophysiol       Date:  2017-05-03       Impact factor: 2.714

5.  Persistent aberrant cortical phase-amplitude coupling following seizure treatment in absence epilepsy models.

Authors:  Atul Maheshwari; Abraham Akbar; Mai Wang; Rachel L Marks; Katherine Yu; Suhyeorn Park; Brett L Foster; Jeffrey L Noebels
Journal:  J Physiol       Date:  2017-09-19       Impact factor: 5.182

6.  Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.

Authors:  Tony Ye; Mitchell J Bartlett; Scott J Sherman; Torsten Falk; Stephen L Cowen
Journal:  Exp Neurol       Date:  2021-03-02       Impact factor: 5.620

7.  Altered Hippocampo-Cerebello-Cortical Circuit in Schizophrenia by a Spatiotemporal Consistency and Causal Connectivity Analysis.

Authors:  Xi Chen; Yuchao Jiang; Lin Chen; Hui He; Li Dong; Changyue Hou; Mingjun Duan; Mi Yang; Dezhong Yao; Cheng Luo
Journal:  Front Neurosci       Date:  2017-01-30       Impact factor: 4.677

8.  Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations.

Authors:  Tony Ye; Mitchell J Bartlett; Matthew B Schmit; Scott J Sherman; Torsten Falk; Stephen L Cowen
Journal:  Front Neural Circuits       Date:  2018-08-13       Impact factor: 3.492

9.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

10.  Subunit-specific NMDAR antagonism dissociates schizophrenia subtype-relevant oscillopathies associated with frontal hypofunction and hippocampal hyperfunction.

Authors:  Benjamin Pittman-Polletta; Kun Hu; Bernat Kocsis
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.